Symptoms and diagnostic delay in ovarian cancer: a summary of the literature - PubMed (original) (raw)
Review
Symptoms and diagnostic delay in ovarian cancer: a summary of the literature
Victoria Jayde et al. Contemp Nurse. 2009.
Abstract
Ovarian cancer is the most common cause of death due to gynaecological cancers in developed countries. The symptoms of ovarian cancer are common female complaints, are non-specific and do not fit any easily recognisable pattern. This frequently leads to a delay in diagnosis. Until an effective screening test becomes available for this disease, increasing the education of women and clinicians regarding the symptoms of ovarian cancer must be seen as a priority. Nurses are ideally placed to disseminate information about the symptoms of ovarian cancer to the community and have a responsibility to do so. It is crucial that nurses are aware of the common symptoms and the usual diagnostic pathway in order to provide empathetic, informed nursing care. This paper draws on the results of a narrative systematic review to describe current knowledge of symptoms of ovarian cancer and describes delays women commonly experience in obtaining a diagnosis.
Similar articles
- 'It whispers, so listen'.
Lehman ML. Lehman ML. RN. 2007 Oct;70(10):28-32; quiz 33. RN. 2007. PMID: 17987818 No abstract available. - Advances in the early detection of ovarian cancer: How to hear the whispers early.
Cesario S. Cesario S. Nurs Womens Health. 2010 Jun;14(3):222-34. doi: 10.1111/j.1751-486X.2010.01543.x. Nurs Womens Health. 2010. PMID: 20579298 No abstract available. - Ovarian cancer: the warning symptoms.
Tate S. Tate S. J Fam Health Care. 2010;20(1):17. J Fam Health Care. 2010. PMID: 20397552 No abstract available. - Epidemiological and genetic factors associated with ovarian cancer.
McLemore MR, Miaskowski C, Aouizerat BE, Chen LM, Dodd MJ. McLemore MR, et al. Cancer Nurs. 2009 Jul-Aug;32(4):281-8; quiz 289-90. doi: 10.1097/NCC.0b013e31819d30d6. Cancer Nurs. 2009. PMID: 19444085 Free PMC article. Review. - The diagnostic journey of ovarian cancer: a review of the literature and suggestions for practice.
Jayde V, Boughton M. Jayde V, et al. Contemp Nurse. 2012 Apr;41(1):5-17. doi: 10.5172/conu.2012.41.1.5. Contemp Nurse. 2012. PMID: 22724902 Review.
Cited by
- RNA m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer.
Liu X, Wei Q, Yang C, Zhao H, Xu J, Mobet Y, Luo Q, Yang D, Zuo X, Chen N, Yang Y, Li L, Wang W, Yu J, Xu J, Liu T, Yi P. Liu X, et al. Exp Mol Med. 2024 Mar;56(3):600-615. doi: 10.1038/s12276-024-01184-4. Epub 2024 Mar 1. Exp Mol Med. 2024. PMID: 38424195 Free PMC article. - A benzimidazolium salt induces apoptosis and arrests cells at sub-G1 phase in epithelial ovarian cancer cells.
Akar S, Cakir M, Ozkol H, Akkoc S, Ozdem B. Akar S, et al. Mol Biol Rep. 2024 Jan 3;51(1):66. doi: 10.1007/s11033-023-08981-6. Mol Biol Rep. 2024. PMID: 38170294 - Coupled Electrostatic and Hydrophobic Destabilisation of the Gelsolin-Actin Complex Enables Facile Detection of Ovarian Cancer Biomarker Lysophosphatidic Acid.
Davoudian K, Bhattacharya S, Thompson D, Thompson M. Davoudian K, et al. Biomolecules. 2023 Sep 21;13(9):1426. doi: 10.3390/biom13091426. Biomolecules. 2023. PMID: 37759826 Free PMC article. - New trends in diagnosing and treating ovarian cancer using nanotechnology.
Zhang J, Ding H, Zhang F, Xu Y, Liang W, Huang L. Zhang J, et al. Front Bioeng Biotechnol. 2023 Apr 4;11:1160985. doi: 10.3389/fbioe.2023.1160985. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37082219 Free PMC article. Review. - Multiple Biomarker Simultaneous Detection in Serum via a Nanomaterial-Functionalized Biosensor for Ovarian Tumor/Cancer Diagnosis.
Wu Y, Wang C, Wang C, Wang P, Chang X, Han L, Zhang Y. Wu Y, et al. Micromachines (Basel). 2022 Nov 22;13(12):2046. doi: 10.3390/mi13122046. Micromachines (Basel). 2022. PMID: 36557345 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical